Anebulo Pharmaceuticals (ANEB) Research & Development (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) recorded Research & Development of $1.16 million in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 4.6% from $1.22 million a year earlier but up 43.8% from the prior quarter.
Anebulo Pharmaceuticals (ANEB) Research & Development (2020 - 2025) Analysis & Trends
On a TTM basis, Anebulo Pharmaceuticals' Research & Development came in at $3.74 million as of Dec 31, 2025, down 0.3% year-over-year; for FY2025 (ended Jun 30, 2025), it was $4.3 million, up 21.2% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 95.6% (FY2020 to FY2025).
- Across earlier fiscal years, Research & Development came in at $3.55 million in FY2024 (-36.6%), $5.6 million in FY2023 (+89.1%), $2.96 million in FY2022 (+30.5%) and $2.27 million in FY2021.
- Quarterly Research & Development has ranged from $212,936 in fiscal Q2 2022 to $1.87 million in fiscal Q2 2023 over the past five years.
- On a year-over-year basis, Research & Development rose in three of the last eight quarters, with growth averaging 0.4%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 778.2% in fiscal Q2 2023, against a decline of 67.0% in fiscal Q4 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $809,991 (Q1 2026), $1.13 million (Q4 2025) and $638,324 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 1.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 809,991.00 |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 638,324.00 |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 467,706.00 |
| Mar 31, 2024 | 748,339.00 |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.12 Mn |
| Mar 31, 2022 | 915,363.00 |
| Dec 31, 2021 | 212,936.00 |
| Sep 30, 2021 | 715,098.00 |
| Jun 30, 2021 | 1.81 Mn |
| Mar 31, 2021 | 273,038.00 |
Anebulo Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();